Douglas Fambrough, Chief Executive Officer at Dicerna Pharmaceuticals Inc (DRNA), bought 33,100 shares at $3.63 ($123K) on 2016-11-15, disclosed to the SEC on 2016-11-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.78 | 16,600 | $63K | 51.2% |
| 2 | $3.63 | 16,500 | $60K | 48.8% |
| Total | $3.71 avg | 33,100 | $123K | 100% |
| Filing → |
| DRNA | SELL | 2019-12-19 | $7.2M | — | Filing → |
| DRNA | BUY | 2014-02-20 | $75K | — | Filing → |